Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy
Stephen P. Chelko, … , Kory Lavine, Jeffrey E. Saffitz
Stephen P. Chelko, … , Kory Lavine, Jeffrey E. Saffitz
Published April 2, 2024
Citation Information: J Clin Invest. 2024;134(10):e172014. https://doi.org/10.1172/JCI172014.
View: Text | PDF | Corrigendum
Research Article Cardiology Immunology Article has an altmetric score of 7

NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy

  • Text
  • PDF
Abstract

Nuclear factor κ-B (NFκB) is activated in iPSC-cardiac myocytes from patients with arrhythmogenic cardiomyopathy (ACM) under basal conditions, and inhibition of NFκB signaling prevents disease in Dsg2mut/mut mice, a robust mouse model of ACM. Here, we used genetic approaches and single-cell RNA-Seq to define the contributions of immune signaling in cardiac myocytes and macrophages in the natural progression of ACM using Dsg2mut/mut mice. We found that NFκB signaling in cardiac myocytes drives myocardial injury, contractile dysfunction, and arrhythmias in Dsg2mut/mut mice. NFκB signaling in cardiac myocytes mobilizes macrophages expressing C-C motif chemokine receptor-2 (CCR2+ cells) to affected areas within the heart, where they mediate myocardial injury and arrhythmias. Contractile dysfunction in Dsg2mut/mut mice is caused both by loss of heart muscle and negative inotropic effects of inflammation in viable muscle. Single nucleus RNA-Seq and cellular indexing of transcriptomes and epitomes (CITE-Seq) studies revealed marked proinflammatory changes in gene expression and the cellular landscape in hearts of Dsg2mut/mut mice involving cardiac myocytes, fibroblasts, and CCR2+ macrophages. Changes in gene expression in cardiac myocytes and fibroblasts in Dsg2mut/mut mice were dependent on CCR2+ macrophage recruitment to the heart. These results highlight complex mechanisms of immune injury and regulatory crosstalk between cardiac myocytes, inflammatory cells, and fibroblasts in the pathogenesis of ACM.

Authors

Stephen P. Chelko, Vinay R. Penna, Morgan Engel, Emily A. Shiel, Ann M. Centner, Waleed Farra, Elisa N. Cannon, Maicon Landim-Vieira, Niccole Schaible, Kory Lavine, Jeffrey E. Saffitz

×

Figure 6

PostN+ fibroblasts are expanded in Dsg2mut/mut hearts through a CCR2+ monocyte- and macrophage-dependent mechanism.

Options: View larger image (or click on image) Download as PowerPoint
PostN+ fibroblasts are expanded in Dsg2mut/mut hearts through a CCR2+ mo...
(A) UMAP re-clustering of fibroblast population. (B) Gaussian kernel density estimation of cells within the fibroblast cluster across the indicated genotypes. (C) Heatmap of top 25 differentially expressed genes in the fibroblast cluster between WT and Dsg2mut/mut mice with sideby-side comparison of the expression of those same genes from Dsg2mut/mut × Ccr2–/– mice. Example genes are annotated. (D) Z-score feature plot, overlaying a fibroblast gene signature derived from the heatmap in C (genes listed to the side) and displayed on the fibroblast UMAP projection, split by genotype. (E) Graph of Z-score values for fibroblast gene signature derived from heatmap in C compared across genotypes. Data presented as a box-and-whisker plot. The 5 number summary (minimum, 25% IQR, median, 75% IQR, and maximum) as well as total number of values for each group is provided as follows; WT: –0.7450, –0.4597, –0.2805, –0.07749, 0.9996, n = 1717; Dsg2mut/mut: –0.6437, –0.008809, 0.2165, 0.4886, 1.611, n = 1675; Dsg2mut/mut × Ccr2–/–: –0.7450, –0.2865, –0.06280, –0.2262, 1,371, n = 2625. P values inset and determined by 1-way ANOVA. (F) Top GO Biological pathways for the top 25 differentially upregulated genes in WT versus Dsg2mut/mut mice (red) and WT versus Dsg2mut/mut × Ccr2–/– mice (blue) (derived from C). (G) Representative immunostained myocardium displaying colocalization of CCR2+ macrophages (green) with Periostin+ (PostN+) fibroblasts (red) at 16 weeks of age. Scale bars: 60 μm. (H) Representative immunostained myocardium depicting PostN+ (red) areas via immunofluorescence staining from mice aged 16 weeks from indicated genotypes. Scale bars: 40 μm. (I) Quantification of PostN+ area as a percentage of total area in mice of the indicated genotypes (P values inset, determined via 1-way ANOVA); WT (n = 5); Dsg2mut/mut (n = 4); and Dsg2mut/mut × Ccr2–/– (n = 4). Data presented as mean ± SEM, n = 4 per cohort, P values inset and determined via 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 10 X users
On 1 Facebook pages
19 readers on Mendeley
See more details